Standout Papers

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in N... 2008 2026 2014 2020 2.7k
  1. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2010)
    Patrick Y. Wen, David R. Macdonald et al. Journal of Clinical Oncology
  2. Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial (2013)
    Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology
  3. Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity (2008)
    Monika E. Hegi, Lili Liu et al. Journal of Clinical Oncology
  4. Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma (2010)
    John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology
  5. Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System (2010)
    Victor A. Levin, Luc Bidaut et al. International Journal of Radiation Oncology*Biology*Physics
  6. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group (2015)
    Hideho Okada, Michael Weller et al. The Lancet Oncology
  7. IDH mutation in glioma: molecular mechanisms and potential therapeutic targets (2020)
    Sue Han, Yang Liu et al. British Journal of Cancer
  8. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy (2018)
    Amber Giles, Marsha-Kay Hutchinson et al. Journal for ImmunoTherapy of Cancer

Immediate Impact

6 by Nobel laureates 5 from Science/Nature 125 standout
Sub-graph 1 of 17

Citing Papers

Causes of death among people living with metastatic cancer
2024 Standout
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
2024 Standout
9 intermediate papers

Works of Mark R. Gilbert being referenced

Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study
2011
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
and 19 more

Author Peers

Author Last Decade Papers Cites
Mark R. Gilbert 14723 6592 5722 6398 482 24.1k
Michael D. Prados 18387 7284 4843 7766 407 27.0k
Allan H. Friedman 11984 4745 5537 7046 340 25.2k
Raymond Sawaya 11284 7079 7808 8341 349 27.7k
Christine Marosi 14391 5483 4415 7088 193 23.8k
Daniel J. Brat 10901 3412 3566 7590 306 22.3k
Alba A. Brandes 23019 9461 6491 9884 356 33.2k
David A. Reardon 20314 7151 8565 10207 552 33.1k
Kenneth Aldape 10822 4678 6478 12693 360 26.8k
Timothy F. Cloughesy 19925 6327 6199 10680 553 32.8k
Martin Taphoorn 14784 5703 3848 6387 152 21.8k

All Works

Loading papers...

Rankless by CCL
2026